Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities-Reference-Cited by-同舟云学术

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities

Published:2001-08 Issue:2 Volume:55 Page:209-216
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Abdu Tarig A. M.,Neary Richard,Elhadd Tarik A.,Akber Mohamed,Clayton Richard N.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2001.01320.x/fullpdf

Reference40 articles.

1. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy;Alford;Journal of Endocrinological Investigation,1999

2. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy;Al-Shoumer;Journal of Clinical Endocrinology and Metabolism,1997

3. Cardiovascular disease risk profiles;Anderson;American Heart Journal,1991

4. Growth hormone induces changes in postheparin plasma lipoprotein lipase and hepatic triglyceridase activities;Asayama;Metabolism,1984

5. The emergence of triglycerides as a significant independent risk factor in coronary artery disease;Assmann;European Heart Journal,1998

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management;Reviews in Endocrine and Metabolic Disorders;2024-05-27

2. Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients;Reviews in Endocrine and Metabolic Disorders;2024-01-25

3. Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone Replacement;Diabetes, Metabolic Syndrome and Obesity;2023-10

4. Sheehan syndrome: Cardiovascular and metabolic comorbidities;Frontiers in Endocrinology;2023-01-20

5. Classic endocrine disorders: implications for cardiovascular disease;Cardiovascular Endocrinology and Metabolism;2023